Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Clinical trial NCT02187133 · COMPLETED
Trial details
- NCT number
- NCT02187133
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-05
- Primary completion
- 2021-03-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.